224 related articles for article (PubMed ID: 10930119)
41. Relationships among the expression of epidermal growth factor receptor, proliferating cell nuclear antigen labeling index, and lymph node metastasis in gastric cancer.
Iida A; Hirose K; Arai M; Yamaguchi A; Nakagawara G
Oncology; 1995; 52(3):189-95. PubMed ID: 7715902
[TBL] [Abstract][Full Text] [Related]
42. Cell cycle regulatory markers in uterine atypical leiomyoma and leiomyosarcoma: immunohistochemical study of 68 cases with clinical follow-up.
Mills AM; Ly A; Balzer BL; Hendrickson MR; Kempson RL; McKenney JK; Longacre TA
Am J Surg Pathol; 2013 May; 37(5):634-42. PubMed ID: 23552380
[TBL] [Abstract][Full Text] [Related]
43. The expression of epidermal growth factor receptor and transforming growth factor alpha in renal cell carcinoma.
Lager DJ; Slagel DD; Palechek PL
Mod Pathol; 1994 Jun; 7(5):544-8. PubMed ID: 7937720
[TBL] [Abstract][Full Text] [Related]
44. Immunohistochemical phenotyping and PCNA detection in gastrointestinal stromal tumors.
Vrettou E; Karkavelas G; Christoforidou B; Meditskou S; Papadimitriou CS
Anticancer Res; 1995; 15(3):943-9. PubMed ID: 7645984
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
Rusch V; Klimstra D; Venkatraman E; Pisters PW; Langenfeld J; Dmitrovsky E
Clin Cancer Res; 1997 Apr; 3(4):515-22. PubMed ID: 9815714
[TBL] [Abstract][Full Text] [Related]
46. Estrogen and progesterone receptor expression in patients with uterine smooth muscle tumors.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
Fertil Steril; 2004 Apr; 81(4):1062-6. PubMed ID: 15066464
[TBL] [Abstract][Full Text] [Related]
47. May Sonic Hedgehog proteins be markers for malignancy in uterine smooth muscle tumors?
Garcia N; Bozzini N; Baiocchi G; da Cunha IW; Maciel GA; Soares Junior JM; Soares FA; Baracat EC; Carvalho KC
Hum Pathol; 2016 Apr; 50():43-50. PubMed ID: 26997437
[TBL] [Abstract][Full Text] [Related]
48. Cell proliferation and expression of EGF, TGF-alpha, and EGF receptor in the developing primary palate.
Iamaroon A; Tait B; Diewert VM
J Dent Res; 1996 Aug; 75(8):1534-9. PubMed ID: 8906120
[TBL] [Abstract][Full Text] [Related]
49. Molecular bases for the actions of ovarian sex steroids in the regulation of proliferation and apoptosis of human uterine leiomyoma.
Matsuo H; Kurachi O; Shimomura Y; Samoto T; Maruo T
Oncology; 1999 Oct; 57 Suppl 2():49-58. PubMed ID: 10545803
[TBL] [Abstract][Full Text] [Related]
50. Immunoexpression of Steroid Hormone Receptors and Proliferation Markers in Uterine Leiomyoma and Normal Myometrial Tissues from the Miniature Pig, Sus scrofa.
Mozzachio K; Moore AB; Kissling GE; Dixon D
Toxicol Pathol; 2016 Apr; 44(3):450-7. PubMed ID: 26692562
[TBL] [Abstract][Full Text] [Related]
51. Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity.
de Graaff MA; Cleton-Jansen AM; Szuhai K; Bovée JV
Hum Pathol; 2013 Aug; 44(8):1597-604. PubMed ID: 23517922
[TBL] [Abstract][Full Text] [Related]
52. Transforming growth factor-alpha, epidermal growth factor receptor, and proliferating potential in benign and malignant gliomas.
Maruno M; Kovach JS; Kelly PJ; Yanagihara T
J Neurosurg; 1991 Jul; 75(1):97-102. PubMed ID: 2045927
[TBL] [Abstract][Full Text] [Related]
53. Immunoexpression of p53 in cutaneous and subcutaneous leiomyosarcomas.
Fernandez-Flores A; Monteagudo C
Ann Diagn Pathol; 2016 Oct; 24():25-9. PubMed ID: 27649950
[TBL] [Abstract][Full Text] [Related]
54. Atypical uterine leiomyoma: a case report and review of the literature.
Manxhuka-Kerliu S; Kerliu-Saliu I; Sahatciu-Meka V; Kerliu L; Shahini L
J Med Case Rep; 2016 Jan; 10():22. PubMed ID: 26801982
[TBL] [Abstract][Full Text] [Related]
55. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
Schwetye KE; Pfeifer JD; Duncavage EJ
Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
[TBL] [Abstract][Full Text] [Related]
56. The values of intratumoral mast cell count and Ki-67 immunoreactivity index in differential diagnosis of uterine smooth muscle neoplasms.
Yavuz E; Güllüoğlu MG; Akbaş N; Tuzlali S; Ilhan R; Iplikçi A; Akhan SE
Pathol Int; 2001 Dec; 51(12):938-41. PubMed ID: 11844066
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic value of progesterone receptor, p16, p53 and pHH3 expression in uterine atypical leiomyoma.
Liang Y; Zhang X; Chen X; Lü W
Int J Clin Exp Pathol; 2015; 8(6):7196-202. PubMed ID: 26261614
[TBL] [Abstract][Full Text] [Related]
58. p53 protein overexpression in smooth muscle tumors of the uterus.
Niemann TH; Raab SS; Lenel JC; Rodgers JR; Robinson RA
Hum Pathol; 1995 Apr; 26(4):375-9. PubMed ID: 7705814
[TBL] [Abstract][Full Text] [Related]
59. Involvement of parathyroid hormone-related peptide in cell proliferation activity of human uterine leiomyomas.
Yoshida M; Ohtsuru A; Samejima T; Okazaki M; Fujishita A; Ito M; Yamashita S; Ishimaru T
Endocr J; 1999 Feb; 46(1):81-90. PubMed ID: 10426571
[TBL] [Abstract][Full Text] [Related]
60. [The differential diagnosis between uterine leiomyosarcoma and the special subtypes of leiomyoma].
Zhu XQ; Shi YF; Cheng XD; Wu YZ
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(16):1419-21. PubMed ID: 14521746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
